Sign in
TerminatedNo phase

Impact of Mitral Regurgitation on Coronary Haemodynamics and Instantaneous Effect of Transcatheter Mitral Valve Repair

Key facts

Who runs it
University Hospital, Geneva
Where
Switzerland1 site in 1 countryChoose a country to see its sites
Trial code
Status
Terminated
People taking part
1 person enrolled
Started
8 Jan 2020
Ended
31 Jan 2025
Type of study
Interventional
Treatments tested
  • Measure of hemodynamic indices in a stenosed coronary artery using a pressure wire
Record updated
4 February 2025
Why it stopped
Slow enrolment

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 16 criteriaShow less

Who can take part

  • Age ≥18 years
  • Patients with significant degenerative or functional MR planned for TMVR with the percutaneous edge-to-edge mitral valve repair MitraClip system
  • Patients with ≥ 1 coronary artery lesion with angiographically-documented ≥50% diameter stenosis,
  • Patient willing and able to provide written informed consent

Who cannot take part

  • Previous coronary artery bypass surgery
  • Acute coronary syndrome with recent ST-elevation myocardial infarction <5 days prior to randomization, or ongoing non-ST elevation acute coronary syndrome with biomarkers (cardiac troponin) still rising
  • Cardiogenic shock/hemodynamic instability at the time of intervention (heart rate<50 beats per minute, systolic blood pressure <90mmHg) and/or need for mechanical/pharmacologic hemodynamic support
  • Significant contraindication to adenosine administration (e.g. heart block, severe asthma)
  • Presence of ≥1 coronary total occlusion(s)
  • Documented non-viable myocardium in the area of the corresponding coronary artery being studied
  • Severe left ventricular systolic dysfunction (<30%)
  • Systolic pulmonary artery pressure > 70 mmHg on baseline echocardiography
  • Extremely calcified or tortuous vessels precluding invasive coronary physiology measurement
  • Hypertrophic cardiomyopathy, restrictive pericarditis, constrictive pericarditis, infiltrative cardiomyopathy
  • Participation or planned participation in another clinical trial, except for observational registries
  • Patients unable or unwilling to provide written informed consent

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

In the present study, the investigators aim to use the in-vivo Transcatheter Mitral Valve Repair (TMVR) model to determine how Mitral Regurgitation (MR) affects coronary hemodynamics in patients affected with severe MR and concomittant angiographically-documented coronary artery disease. The investigators will also provide unique physiologic data on the acute effect of TMVR using the MitraClip system on coronary microcirculation in patients with severe MR.

The group in the trial

  • Transcatheter Mitral Valve Repair armTreatment being tested

    Patients with severe Mitral Insufficiency with concomitant intermediate coronary artery stenosis undergoing Transcatheter Mitral Valve Repair using the percutaneous edge-to-edge MitraClip system

    Treatment: Measure of hemodynamic indices in a stenosed coronary artery using a pressure wire

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Impact of Mitral Valve Regurgitation on Coronary Haemodynamics and the Instantaneous Effect of Transcatheter Mitral Valve Repair: The MitraFLOW Study
Record updated
4 February 2025